Aldesleukin Terminated Phase 1 Trials for Metastatic Cancers / Melanoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01585415Vemurafenib and White Blood Cell Therapy for Advanced Melanoma
NCT00923806Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer